<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
<journal-id journal-id-type="publisher-id">J Clin Invest</journal-id>
<journal-title-group>
<journal-title>The Journal of Clinical Investigation</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9738</issn>
<issn pub-type="epub">1558-8238</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30614812</article-id>
<article-id pub-id-type="pmc">6355220</article-id>
<article-id pub-id-type="publisher-id">121277</article-id>
<article-id pub-id-type="doi">10.1172/JCI121277</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Series</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>PTEN-opathies: from biological insights to evidence-based precision medicine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6389-3059</contrib-id>
<name>
<surname>Yehia</surname>
<given-names>Lamis</given-names>
</name>
<email>yehial@ccf.org</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ngeow</surname>
<given-names>Joanne</given-names>
</name>
<email>jongeow@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3693-5145</contrib-id>
<name>
<surname>Eng</surname>
<given-names>Charis</given-names>
</name>
<email>engc@ccf.org</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.</aff>
<aff id="A2"><label>2</label>Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.</aff>
<aff id="A3"><label>3</label>Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre, Singapore.</aff>
<aff id="A4"><label>4</label>Oncology Academic Program, Duke-NUS Graduate Medical School, Singapore.</aff>
<aff id="A5"><label>5</label>Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.</aff>
<aff id="A6"><label>6</label>Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.</aff>
<aff id="A7"><label>7</label>Germline High Risk Cancer Focus Group, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Charis Eng, Cleveland Clinic Genomic Medicine Institute, 9500 Euclid Avenue NE50, Cleveland, Ohio 44195, USA. Phone: 216.444.3440; Email: <email>engc@ccf.org</email>.</corresp>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> The authors have declared that no conflict of interest exists.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2019-01-07T16:00:00-0500" publication-format="electronic">
<day>7</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2019-01-07T16:00:00-0500" publication-format="electronic">
<day>7</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date date-type="pub" iso-8601-date="2019-02-01T16:00:00-0500" publication-format="print">
<day>1</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>2</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>129</volume>
<issue>2</issue>
<fpage>452</fpage>
<lpage>464</lpage>
<permissions>
<copyright-statement>Copyright © 2019, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://www.jci.org/articles/view/121277">This article is available online at https://www.jci.org/articles/view/121277</self-uri>
<abstract>
<p>The tumor suppressor phosphatase and tensin homolog (PTEN) classically counteracts the PI3K/AKT/mTOR signaling cascade. Germline pathogenic <italic>PTEN</italic> mutations cause <italic>PTEN</italic> hamartoma tumor syndrome (PHTS), featuring various benign and malignant tumors, as well as neurodevelopmental disorders such as autism spectrum disorder. Germline and somatic mosaic mutations in genes encoding components of the PI3K/AKT/mTOR pathway downstream of PTEN predispose to syndromes with partially overlapping clinical features, termed the “PTEN-opathies.” Experimental models of PTEN pathway disruption uncover the molecular and cellular processes influencing clinical phenotypic manifestations. Such insights not only teach us about biological mechanisms in states of health and disease, but also enable more accurate gene<italic>-</italic>informed cancer risk assessment, medical management, and targeted therapeutics. Hence, the PTEN<italic>-</italic>opathies serve as a prototype for bedside to bench, and back to the bedside, practice of evidence-based precision medicine.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>